Details for 2018733442
Up to date per 01.04.2026
Actions
Details for 2018733442
Deleted
European Patent
08.04.2020 A
03.04.2024 B1
02.06.2017
US
201762514474 P
A61P 25/08 20060101AFI20230824BHEP
Owner
Xeris Pharmaceuticals, Inc.1375 West Fulton Street, Suite 1300 Chicago, IL 60607US
Representative
Representative
Patentanwaltskanzlei Matschnig & Forsthuber OGBiberstraße 221010 WienAT
Inventor
PRESTRELSKI, Steven J.c/o Xeris Pharmaceuticals, Inc. 180 N. LaSalle Street Suite 1600 Chicago Illinois 60601US
SANDOVAL, Michael A.c/o Xeris Pharmaceuticals, Inc. 180 N. LaSalle Street Suite 1600 Chicago Illinois 60601US
SLOAT, Brian R.c/o Xeris Pharmaceuticals, Inc. 180 N. LaSalle Street Suite 1600 Chicago Illinois 60601US